Telsey Advisory Group analyst Joseph Feldman reiterated the Outperform rating on Target Corporation (NYSE:TGT), lowering the price forecast from $145 to $130. Target will report its first-quarter earnings on Wednesday, May 21. Analyst Feldman lowered first-quarter and full-year 2025 estimates for Target, citing weaker consumer spending, particularly in discretionary and general merchandise, along with rising costs tied to promotions, labor, tech investments, and potential tariff impacts. While Placer.ai data showed declining traffic early in the quarter with some recovery later, likely from Easter timing and improved weather, Feldman noted that Target’s efforts in value offerings, loyalty programs, private label expansion, store upgrades, and brand partnerships (Apple Inc. (NASDAQ: AAPL), Walt Disney Company (NYSE:DIS), Levi Strauss & Co (NYSE:LEVI), Ulta Beauty, Inc. (NASDAQ:ULTA)) could partially offset pressure. Also Read: Pentair To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Friday Feldman now projects total sales to fall 0.9% to $24.3 billion, with comparable sales to decline 1.5%, down from the prior forecast of 1.0% and below the FactSet consensus of a 1.2% drop. Feldman noted that Target sources roughly 50% of its cost of goods sold from within the U.S., while reducing its reliance on China from about 60% in 2017 to about 30% in 2024, with plans to bring that below 25% by 2026. Although the company hasn’t quantified the tariff impact, it plans to mitigate risks through sourcing diversification, vendor negotiations, and price increases while preserving balance sheet flexibility. Reflecting softer consumer demand, a weaker product mix, and added cost pressures, especially tariffs, Feldman lowered his 2025 EPS estimate to $8.80 from $9.30 (vs. FactSet’s $8.62) and 2026 EPS to $9.55 from $10.14 (vs. FactSet’s $9.20). Price Action: TGT shares are trading higher by 1.68% to $98.62 at last check on Friday. Read Next: Emerging Markets Break Out As ‘Peace Trades’ Gain Momentum, Hartnett Says Image by bluestork via Shutterstock Latest Ratings for TGT Date Firm Action From To Mar 2022 Raymond James Maintains Strong Buy Mar 2022 JP Morgan Maintains Overweight Mar 2022 Deutsche Bank Maintains Buy View More Analyst Ratings for TGT View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? TARGET (TGT): Free Stock Analysis Report Story Continues This article Analyst Lowers Target Q1 Forecast Amid Spending Slump, Rising Consumer Tariffs originally appeared on Benzinga.com © 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. View Comments
Analyst Lowers Target Q1 Forecast Amid Spending Slump, Rising Consumer Tariffs
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...